Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Salcedo Website

Rosalba Salcedo, Ph.D.

Selected Publications
1)  Zaragoza IP, Vergara J, Pérez-Manríquez L, Salcedo R.
A DFT study of addition reaction between fragment ion (CH(2)) units and fullerene (C (60)) molecule.
J Mol Model. 17: 1035-40, 2011. [Journal]
2)  Pérez-Manríquez L, Cabrera A, Sansores LE, Salcedo R.
Aromaticity in cyanuric acid.
J Mol Model. 2010. [Journal]
3)  Garg H, Salcedo R, Trinchieri G, Blumenthal R.
Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax.
Cancer Gene Ther. 17: 155-63, 2010. [Journal]
4)  Chibante VG, Fonseca AM, Salcedo RR.
Modeling dry-scrubbing of gaseous HCl with hydrated lime in cyclones with and without recirculation.
J. Hazard. Mater. 178: 469-82, 2010. [Journal]
5)  Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O'hUigin C, Marincola FM, Trinchieri G.
MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18.
J. Exp. Med. 207: 1625-36, 2010. [Journal]
6)  Sangaletti S, Tripodo C, Ratti C, Piconese S, Porcasi R, Salcedo R, Trinchieri G, Colombo MP, Chiodoni C.
Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis.
Cancer Res. 70: 7764-75, 2010. [Journal]
7)  Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T, Dai RM, Scheetz L, Lincoln E, Back TC, Powell D, Hurwitz AA, Sayers TJ, Kastelein R, Pavlakis GN, Felber BK, Trinchieri G, Wigginton JM.
Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.
J. Immunol. 182: 4328-38, 2009. [Journal]
8)  Muñiz J, Sansores LE, Pyykkö P, Martínez A, Salcedo R.
Theoretical study on the series of [Au(3)Cl (3)M (2)] complexes, with M = Li, Na, K, Rb, Cs.
J Mol Model. 15: 1165-73, 2009. [Journal]
9)  Kortylewski M, Kujawski M, Herrmann A, Yang C, Wang L, Liu Y, Salcedo R, Yu H.
Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.
Cancer Res. 69: 2497-505, 2009. [Journal]
10)  Guadarrama P, Fomine S, Salcedo R, Martínez A.
Construction of simplified models to simulate estrogenic disruptions by esters of 4-hydroxy benzoic acid (parabens).
Biophys. Chem. 137: 1-6, 2008. [Journal]
11)  Zaragoza IP, Salcedo R, Vergara J.
DFT: a dynamic study of the interaction of ethanol and methanol with platinum.
Journal of molecular modeling. 2008. [Journal]
12)  Zaragoza IP, Salcedo R, Miranda-Ordoñez U, Muñiz J, Sansores LE.
Electronic analysis of vanadium and iron complexes containing distorted aromatic rings.
Journal of molecular modeling. 14: 1003-8, 2008. [Journal]
13)  Muñiz J, Enrique Sansores L, Martínez A, Salcedo R.
Theoretical study of the novel sandwich compound [Au3Cl3Tr 2]2+.
Journal of molecular modeling. 14: 417-25, 2008. [Journal]
14)  Arroyo M, Sansores LE, Salcedo R, Montoya JA.
Theoretical study of vanadium oxides interaction with Y-zeolite.
J Nanosci Nanotechnol. 8: 6398-405, 2008. [Journal]
15)  Salcedo R.
Aromaticity and electronic properties of Heterosuperbenzene (Heterohexabenzocoronene).
Journal of molecular modeling. 13: 1027-31, 2007. [Journal]
16)  Chibante V, Fonseca A, Salcedo R.
Dry scrubbing of acid gases in recirculating cyclones.
J. Hazard. Mater. 144: 682-6, 2007. [Journal]
17)  Stauffer JK, Khan T, Salcedo R, Hixon JA, Lincoln E, Back TC, Wigginton JM.
Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors.
J. Immunother. 29: 151-64, 2006. [Journal]
18)  Khan T, Stauffer JK, Williams R, Hixon JA, Salcedo R, Lincoln E, Back TC, Powell D, Lockett S, Arnold AC, Sayers TJ, Wigginton JM.
Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors.
J. Immunol. 176: 6302-12, 2006. [Journal]
19)  Zhou Y, Bian X, Le Y, Gong W, Hu J, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OM, Farrar W, Wang JM.
Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
J. Natl. Cancer Inst. 97: 823-35, 2005. [Journal]
20)  Salcedo R, Stauffer JK, Lincoln E, Back TC, Hixon JA, Hahn C, Shafer-Weaver K, Malyguine A, Kastelein R, Wigginton JM.
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.
J. Immunol. 173: 7170-82, 2004. [Journal]
21)  Zolotukhin M, Fomine S, Salcedo R, Khalilov L.
Remarkable enhancement of reactivity of carbonyl compounds for polymerizations with non-activated aromatic hydrocarbons.
Chem. Commun. (Camb.). 1030-1, 2004. [Journal]
22)  Salcedo R, Zhang X, Young HA, Michael N, Wasserman K, Ma WH, Martins-Green M, Murphy WJ, Oppenheim JJ.
Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells.
Blood. 102: 1966-77, 2003. [Journal]
23)  Guadarrama P, Fomine S, Salcedo R.
Cyclen substitution with urea-containing dendrimeric branches. Theoretical study considering the concept of collectivity.
Journal of molecular modeling. 9: 273-82, 2003. [Journal]
24)  Salcedo R, Oppenheim JJ.
Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses.
Microcirculation (New York, N.Y. : 1994). 10: 359-70, 2003. [Journal]
25)  Chen X, Beutler JA, McCloud TG, Loehfelm A, Yang L, Dong HF, Chertov OY, Salcedo R, Oppenheim JJ, Howard OM.
Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.
Clin. Cancer Res. 9: 3115-23, 2003. [Journal]
26)  Salcedo R, Martins-Green M, Gertz B, Oppenheim JJ, Murphy WJ.
Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts.
Clin. Cancer Res. 8: 2655-65, 2002. [Journal]
27)  Schneider GP, Salcedo R, Dong HF, Kleinman HK, Oppenheim JJ, Howard OM.
Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1alpha.
Clin. Cancer Res. 8: 3955-60, 2002. [Journal]
28)  Martínez A, Salcedo R, Sansores LE, Medina G, Gasque L.
A density functional study of the reactivity and stability of mixed copper complexes. Is hardness the reason?.
Inorganic chemistry. 40: 301-6, 2001. [Journal]
29)  Espinosa P M, Campero A, Salcedo R.
Electron spin resonance and electronic structure of vanadyl-porphyrin in heavy crude oils.
Inorganic chemistry. 40: 4543-9, 2001. [Journal]
30)  Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, Oppenheim JJ.
Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.
J. Immunol. 166: 7571-8, 2001. [Journal]
31)  Schneider GP, Salcedo R, Welniak LA, Howard OM, Murphy WJ.
The diverse role of chemokines in tumor progression: prospects for intervention (Review).
Int. J. Mol. Med. 8: 235-44, 2001. [Journal]
32)  Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, Funakoshi S, Asai O, Herrmann SH, Wang JM, Kwak LW, Oppenheim JJ.
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens.
Int. Immunol. 12: 691-700, 2000. [Journal]
33)  Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ.
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
FASEB J. 14: 2055-64, 2000. [Journal]
34)  Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ.
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Blood. 96: 34-40, 2000. [Journal]
35)  Festoff BW, D'Andrea MR, Citron BA, Salcedo RM, Smirnova IV, Andrade-Gordon P.
Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin.
Mol. Med. 6: 410-29, 2000. [Journal]
36)  Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ.
Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
Am. J. Pathol. 154: 1125-35, 1999. [Journal]
37)  Monteón F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, Salcedo RM, García E, Matos M, Kaji J, Vázquez R, Ramos A, Schettino MA, Moran J.
Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group.
Kidney Int. 54: 2123-8, 1998. [Journal]
38)  Salcedo RM, Festoff BW, Citron BA.
Quantitative reverse transcriptase PCR to gauge increased protease-activated receptor 1 (PAR-1) mRNA copy numbers in the Wobbler mutant mouse.
J. Mol. Neurosci. 10: 113-9, 1998. [Journal]
39)  Salcedo R, Segura C, Szekely L, de Mesquita R, Biberfeld P, Patarroyo M.
Endogenous fibronectin of blood polymorphonuclear leukocytes: immunochemical characterization and subcellular localization.
Exp. Cell Res. 233: 25-32, 1997. [Journal]
40)  Salcedo R, Wasserman K, Patarroyo M.
Endogenous fibronectin of blood polymorphonuclear leukocytes: stimulus-induced secretion and proteolysis by cell surface-bound elastase.
Exp. Cell Res. 233: 33-40, 1997. [Journal]
41)  Salcedo R, Valdivia M, Zapata C.
[Laparoscopy as a clinical diagnostic method at a hospital center in Peru].
Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú. 16: 34-8, 1996. [Journal]
42)  Laucella S, Salcedo R, Castaños-Velez E, Riarte A, De Titto EH, Patarroyo M, Orn A, Rottenberg ME.
Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi.
Parasite Immunol. 18: 227-39, 1996. [Journal]
43)  Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R.
The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes.
Eur. J. Biochem. 238: 325-32, 1996. [Journal]
44)  Salcedo R, Patarroyo M.
Constitutive alpha V beta 3 integrin-mediated adhesion of human lymphoid B cells to vitronectin substrate.
Cell. Immunol. 160: 165-72, 1995. [Journal]
45)  Nortamo P, Salcedo R, Timonen T, Patarroyo M, Gahmberg CG.
A monoclonal antibody to the human leukocyte adhesion molecule intercellular adhesion molecule-2. Cellular distribution and molecular characterization of the antigen.
J. Immunol. 146: 2530-5, 1991. [Journal]
46)  Seth R, Salcedo R, Patarroyo M, Makgoba MW.
ICAM-2 peptides mediate lymphocyte adhesion by binding to CD11a/CD18 and CD49d/CD29 integrins.
FEBS Lett. 282: 193-6, 1991. [Journal]
47)  Salcedo R, Fuerstenberg SM, Patarroyo M, Winberg G.
The Epstein-Barr virus BNLF-1 membrane protein LMP1 induces homotypic adhesion mediated by CD11a/CD18 in a murine B-cell line, mimicking the action of phorbol ester.
J. Virol. 65: 5558-63, 1991. [Journal]
48)  Gahmberg CG, Nortamo P, Kantor C, Autero M, Kotovuori P, Hemiö L, Salcedo R, Patarroyo M.
The pivotal role of the Leu-CAM and ICAM molecules in human leukocyte adhesion.
Cell Differ. Dev. 32: 239-45, 1990. [Journal]
49)  Skibber JM, Lotze MT, Seipp CA, Salcedo R, Rosenberg SA.
Limb-sparing surgery for soft tissue sarcomas: wound related morbidity in patients undergoing wide local excision.
Surgery. 102: 447-52, 1987. [Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 5/19/2011.